(Q42997461)

English

Peroxisome proliferator-activated receptor-alpha and -gamma mRNA levels are reduced in chronic hepatitis C with steatosis and genotype 3 infection

scientific article published in January 2006

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

12 November 2017

Peroxisome proliferator-activated receptor-alpha and -gamma mRNA levels are reduced in chronic hepatitis C with steatosis and genotype 3 infection (English)

1 reference

Europe PubMed Central

12 November 2017

1 reference

based on heuristic

inferred from title

chronic hepatitis C

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

chronic hepatitis

1 reference

based on heuristic

inferred from title

Valerio Pazienza

2

1 reference

Europe PubMed Central

12 November 2017

author name string

de Gottardi A

1

1 reference

Europe PubMed Central

12 November 2017

Pugnale P

3

1 reference

Europe PubMed Central

12 November 2017

Bruttin F

4

1 reference

Europe PubMed Central

12 November 2017

Rubbia-Brandt L

5

1 reference

Europe PubMed Central

12 November 2017

Juge-Aubry CE

6

1 reference

Europe PubMed Central

12 November 2017

Meier CA

7

1 reference

Europe PubMed Central

12 November 2017

Hadengue A

8

1 reference

Europe PubMed Central

12 November 2017

Negro F

9

1 reference

Europe PubMed Central

12 November 2017

language of work or name

0 references

publication date

1 January 2006

1 reference

Europe PubMed Central

12 November 2017

Alimentary Pharmacology & Therapeutics

1 reference

Europe PubMed Central

12 November 2017

23

1 reference

Europe PubMed Central

12 November 2017

1

1 reference

Europe PubMed Central

12 November 2017

107-114

1 reference

Europe PubMed Central

12 November 2017

Prognosis of chronic hepatitis C: results of a large, prospective cohort study.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2006.02729.X

21 January 2018

Correlation of genotypes and route of transmission with histologic activity and disease stage in chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2006.02729.X

21 January 2018

Age and platelet count: a simple index for predicting the presence of histological lesions in patients with antibodies to hepatitis C virus. METAVIR and CLINIVIR Cooperative Study Groups

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2006.02729.X

21 January 2018

Role of alcohol in the progression of liver disease caused by hepatitis C virus infection

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2006.02729.X

21 January 2018

Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2006.02729.X

21 January 2018

Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2006.02729.X

21 January 2018

Analysis of histopathological manifestations of chronic hepatitis C virus infection with respect to virus genotype

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2006.02729.X

21 January 2018

Hepatocyte steatosis is a cytopathic effect of hepatitis C virus genotype 3.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2006.02729.X

21 January 2018

Expression of liver steatosis in hepatitis C virus infection and pattern of response to alpha-interferon

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2006.02729.X

21 January 2018

Steatosis accelerates the progression of liver damage of chronic hepatitis C patients and correlates with specific HCV genotype and visceral obesity

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2006.02729.X

21 January 2018

Steatosis affects chronic hepatitis C progression in a genotype specific way

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2006.02729.X

21 January 2018

Impact of steatosis on progression of fibrosis in patients with mild hepatitis C.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2006.02729.X

21 January 2018

Identification of peroxisome proliferator-responsive human genes by elevated expression of the peroxisome proliferator-activated receptor alpha in HepG2 cells

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2006.02729.X

21 January 2018

PPAR gamma 2 regulates adipose expression of the phosphoenolpyruvate carboxykinase gene

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2006.02729.X

21 January 2018

Central role of PPARalpha-dependent hepatic lipid turnover in dietary steatohepatitis in mice

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2006.02729.X

21 January 2018

Adipocyte-specific gene expression and adipogenic steatosis in the mouse liver due to peroxisome proliferator-activated receptor gamma1 (PPARgamma1) overexpression

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2006.02729.X

21 January 2018

Impaired expression of the peroxisome proliferator-activated receptor alpha during hepatitis C virus infection.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2006.02729.X

21 January 2018

An in vitro model of hepatitis C virus genotype 3a-associated triglycerides accumulation

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2006.02729.X

21 January 2018

Molecular mechanisms of alcoholic fatty liver: role of sterol regulatory element-binding proteins

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2006.02729.X

21 January 2018

Hepatitis C virus core protein inhibits microsomal triglyceride transfer protein activity and very low density lipoprotein secretion: a model of viral-related steatosis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2006.02729.X

21 January 2018

Steatosis accelerates fibrosis development over time in hepatitis C virus genotype 3 infected patients

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2006.02729.X

21 January 2018

Worsening of steatosis is an independent factor of fibrosis progression in untreated patients with chronic hepatitis C and paired liver biopsies.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2006.02729.X

21 January 2018

The impact of steatosis on disease progression and early and sustained treatment response in chronic hepatitis C patients

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2006.02729.X

21 January 2018

Reduced expression of peroxisome proliferator-activated receptor-alpha may have an important role in the development of non-alcoholic fatty liver disease.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2006.02729.X

21 January 2018

Liver peroxisome proliferator-activated receptor gamma contributes to hepatic steatosis, triglyceride clearance, and regulation of body fat mass.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2006.02729.X

21 January 2018

Pioglitazone prevents hepatic steatosis, fibrosis, and enzyme-altered lesions in rat liver cirrhosis induced by a choline-deficient L-amino acid-defined diet

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2006.02729.X

21 January 2018

Pioglitazone prevents alcohol-induced fatty liver in rats through up-regulation of c-Met

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2006.02729.X

21 January 2018

PPARalpha /gamma ragaglitazar eliminates fatty liver and enhances insulin action in fat-fed rats in the absence of hepatomegaly

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2006.02729.X

21 January 2018

Peroxisome proliferator-activated receptors and hepatic stellate cell activation

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2006.02729.X

21 January 2018

Identifiers

10.1111/J.1365-2036.2006.02729.X

1 reference

Europe PubMed Central

12 November 2017

1 reference

Europe PubMed Central

12 November 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q42997461&oldid=1976304094"